The US Food and Drug Administration (FDA) has approved the Amplatzer Piccolo Occluder (Abbott), the first medical device to treat patent ductus arteriosus (PDA) in premature babies weighing as little ...
First and only delivery system designed specifically for premature infants with a patent ductus arteriosus (PDA), a life-threatening opening in their heart New delivery system enables precise ...
Add Yahoo as a preferred source to see more of our stories on Google. Abbott’s range of paediatric heart treatments also includes the Masters HP 15mm mechanical heart valve. Credit: Michael Vi / ...
Chicago-based Abbott Laboratories received an FDA approval for the Amplatzer Piccolo Occluder to treat patent ductus arteriosus (PDA), a condition in which a newborn has a persistent opening in the ...
(RTTNews) - Abbott (ABT) Thursday said it has received U.S. Food and Drug Administration clearance and CE Mark approval for its Amplatzer Piccolo Delivery System, designed to treat premature babies ...
The healthcare company released highly encouraging data on an important pediatric device. Three years of data on the Amplatzer Piccolo Occluder show an extremely high survival rate in patients. Abbott ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results